Literature DB >> 23077101

Extracellular 2',3'-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cells.

Edwin K Jackson1, Delbert G Gillespie.   

Abstract

In a previous study, we demonstrated that human proximal tubular epithelial cells obtained from a commercial source metabolized extracellular 2',3'-cAMP to 2'-AMP and 3'-AMP and extracellular 2'-AMP and 3'-AMP to adenosine (the extracellular 2',3'-cAMP-adenosine pathway; extracellular 2',3'-cAMP2'-AMP + 3'-AMPadenosine). The purpose of this study was to investigate the metabolism of extracellular 2',3'-cAMP in proximal tubular vs. thick ascending limb vs. collecting duct epithelial cells freshly isolated from their corresponding nephron segments obtained from rat kidneys. In epithelial cells from all three nephron segments, 1) extracellular 2',3'-cAMP was metabolized to 2'-AMP and 3'-AMP, with 2'-AMP > 3'-AMP, 2) the metabolism of extracellular 2',3'-cAMP to 2'-AMP and 3'-AMP was not inhibited by either 3-isobutyl-1-methylxanthine (phosphodiesterase inhibitor) or 1,3-dipropyl-8-p-sulfophenylxanthine (ecto-phosphodiesterase inhibitor), 3) extracellular 2',3'-cAMP increased extracellular adenosine levels, 4) 3'-AMP and 2'-AMP were metabolized to adenosine with an efficiency similar to that of 5'-AMP, and 5) the metabolism of 5'-AMP, 3'-AMP, and 2'-AMP was not inhibited by α,β-methylene-adenosine-5'-diphosphate (CD73 inhibitor). These results support the conclusion that renal epithelial cells all along the nephron can metabolize extracellular 2',3'-cAMP to 2'-AMP and 3'-AMP and can efficiently metabolize extracellular 2'-AMP and 3'-AMP to adenosine and that the metabolic enzymes involved are not the classical phosphodiesterases nor ecto-5'-nucleotidase (CD73). Because 2',3'-cAMP is released by injury and because previous studies demonstrate that the extracellular 2',3'-cAMP-adenosine pathway stimulates epithelial cell proliferation via adenosine A(2B) receptors, the present results suggest that the extracellular 2',3'-cAMP-adenosine pathway may help restore epithelial cells along the nephron following kidney injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23077101      PMCID: PMC3543616          DOI: 10.1152/ajprenal.00571.2012

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  31 in total

Review 1.  5'-Nucleotidase: molecular structure and functional aspects.

Authors:  H Zimmermann
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

Review 2.  Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors.

Authors:  J A Beavo; D H Reifsnyder
Journal:  Trends Pharmacol Sci       Date:  1990-04       Impact factor: 14.819

3.  Cyclic AMP metabolism by swine adipocyte microsomal and plasma membranes.

Authors:  L A Zacher; G B Carey
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1999-09       Impact factor: 2.231

Review 4.  A(2A) adenosine receptor: a novel therapeutic target in renal disease.

Authors:  Mark D Okusa
Journal:  Am J Physiol Renal Physiol       Date:  2002-01

5.  A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion.

Authors:  M D Okusa; J Linden; L Huang; J M Rieger; T L Macdonald; L P Huynh
Journal:  Am J Physiol Renal Physiol       Date:  2000-11

6.  Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.

Authors:  M D Okusa; J Linden; L Huang; D L Rosin; D F Smith; G Sullivan
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

7.  Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney.

Authors:  M D Okusa; J Linden; T Macdonald; L Huang
Journal:  Am J Physiol       Date:  1999-09

8.  Adenosine attenuates oxidant injury in human proximal tubular cells via A(1) and A(2a) adenosine receptors.

Authors:  H T Lee; Charles W Emala
Journal:  Am J Physiol Renal Physiol       Date:  2002-05

9.  Adenosine biosynthesis in the collecting duct.

Authors:  Edwin K Jackson; Zaichuan Mi; Chongxue Zhu; Raghvendra K Dubey
Journal:  J Pharmacol Exp Ther       Date:  2003-10-14       Impact factor: 4.030

10.  Metabolism of exogenous cyclic AMP to adenosine in the rat kidney.

Authors:  Z Mi; E K Jackson
Journal:  J Pharmacol Exp Ther       Date:  1995-05       Impact factor: 4.030

View more
  8 in total

1.  2',3'-cGMP exists in vivo and comprises a 2',3'-cGMP-guanosine pathway.

Authors:  Edwin K Jackson; Zaichuan Mi; Keri Janesko-Feldman; Travis C Jackson; Patrick M Kochanek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-02-21       Impact factor: 3.619

2.  Urine metabolomics reveals biomarkers and the underlying pathogenesis of diabetic kidney disease.

Authors:  Zeyu Zhang; Maolin Luo; Yongping Lu; Weifeng Feng; Hongwei Wu; Lijing Fan; Baozhang Guan; Yong Dai; Donge Tang; Xiangnan Dong; Chen Yun; Berthold Hocher; Haiping Liu; Qiang Li; Lianghong Yin
Journal:  Int Urol Nephrol       Date:  2022-10-18       Impact factor: 2.266

3.  Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury.

Authors:  Tobias Eckle; Kelly Hughes; Heidi Ehrentraut; Kelley S Brodsky; Peter Rosenberger; Doo-Sup Choi; Katya Ravid; Tingting Weng; Yang Xia; Michael R Blackburn; Holger K Eltzschig
Journal:  FASEB J       Date:  2013-04-19       Impact factor: 5.191

Review 4.  Extracellular nucleotide and nucleoside signaling in vascular and blood disease.

Authors:  Marco Idzko; Davide Ferrari; Ann-Kathrin Riegel; Holger K Eltzschig
Journal:  Blood       Date:  2014-07-07       Impact factor: 22.113

Review 5.  Purines: forgotten mediators in traumatic brain injury.

Authors:  Edwin K Jackson; Detlev Boison; Michael A Schwarzschild; Patrick M Kochanek
Journal:  J Neurochem       Date:  2016-02-25       Impact factor: 5.372

6.  Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver.

Authors:  Michael A Zimmerman; Almut Grenz; Eunyoung Tak; Maria Kaplan; Douglas Ridyard; Kelley S Brodsky; Mercedes Susan Mandell; Igal Kam; Holger K Eltzschig
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-28       Impact factor: 11.205

Review 7.  Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

Authors:  Caroline R Sussman; Xiaofang Wang; Fouad T Chebib; Vicente E Torres
Journal:  Cell Signal       Date:  2020-04-23       Impact factor: 4.315

8.  A novel adenosine precursor 2',3'-cyclic adenosine monophosphate inhibits formation of post-surgical adhesions.

Authors:  Mervyn B Forman; Delbert G Gillespie; Dongmei Cheng; Edwin K Jackson
Journal:  Dig Dis Sci       Date:  2014-04-08       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.